Searched for
MV RAMANA
Dr Reddy's launches oral semaglutide biosimilar Obeda in IndiaDr. Reddy's Laboratories proudly presents Obeda, a groundbreaking oral semaglutide biosimilar for managing Type 2 diabetes in India. This i...- Dr Reddy's and Nestle Health Science strengthen presence in diabetes, obesity nutrition spaceDr Reddy's teams up with Nestle Health Science to introduce Celevida GLP+, a specialized supplement crafted for those navigating the challe...
- Dr Reddy's readies day-1 launch of semaglutide genericDr Reddy's Laboratories is set to launch a generic version of semaglutide in India on March 21. The company plans to offer both oral and in...
- Dr Reddy’s gets nod to make generic semaglutide for weight lossDr Reddy's Laboratories is set to launch generic semaglutide, a popular weight loss drug. An expert committee has approved their proposal. ...
- Dr Reddy's inks pact with Johnson & Johnson to acquire vertigo treatment brandDr. Reddy's Laboratories has finalized its acquisition of the Stugeron brand from Johnson & Johnson, encompassing EMEA regions, India, and ...
- Dr Reddy's launches novel drug for chronic constipation managementDr Reddy's Laboratories has introduced Colozo, a generic drug for chronic constipation in India. This medication, Linaclotide, is approved ...
- Dr Reddy's to introduce Sanofi's novel drug in IndiaDr. Reddy's Laboratories has expanded its partnership with Sanofi Healthcare to introduce Beyfortus, a novel drug preventing lower respirat...
- Dr Reddy's launches immuno-oncology drug Toripalimab in India for treating nasopharyngeal carcinomaDr. Reddy's Laboratories launched Zytorvi (Toripalimab), a novel immunotherapy drug for recurrent or metastatic nasopharyngeal carcinoma (N...
- Dr Reddy's launches medication to treat chronic constipationDr Reddy's Laboratories has launched BixiBat, a new drug for chronic constipation in India. It is the first company to receive approval fro...
- Dr Reddy's inks licensing pact with Takeda to sell gastrointestinal drugNew Delhi: Dr Reddy's Laboratories, a Hyderabad-based firm, and Takeda Pharmaceutical entered a non-exclusive licensing pact to market 10mg...
- Dr Reddy's launches migraine management device in EuropeThe launch marks the company's entry into digital therapeutics in Europe, the Hyderabad-based drug major said in a statement. Nerivio is ap...
- Dr Reddy's rolls out wearable device for migraine managementDr Reddy's Laboratories has introduced Nerivio, a wearable therapy device for drug-free migraine management, approved by the US FDA. Nerivi...
- Dr Reddy's sells cosmetic derma brands to Eris for Rs 275 crore“India is a focus market for us. We aspire to break into the top 5 in India," said M.V. Ramana, CEO – Branded Markets (India & Emerging Mar...
- SC deliberately flooded with papers to prevent judges from taking up cases: CJI MV RamanaPaperwork despite the court promoting e-filing, and cutting down on insisting on physical copies has always been the bane of the justice de...
- Aster DM Healthcare partners with Dr Reddy's to administer Sputnik V vaccine in select locationsThe Kochi-based healthcare provider would initially inoculate beneficiaries in (Kochi) Kerala and Kolhapur (Maharashtra) as part of the ini...
- Manipal Hospitals to offer Sputnik V later this monthThe Russian vaccine is currently under pilot at Manipal, and the hospital chain hopes to roll it out for the public after the second week o...
- Dr Reddy's launches Hervycta to treat cancer in IndiaQuoting Ipsos data, the company said the Herceptin and its biosimilars had India sales of Rs 290 crore for the most recent 12 months ending...
- Dr Reddy's launches pain relief spray in Indian marketThe spray will be available across the country in two sizes -- pocket pack at Rs 99 and home pack for Rs 130 -- Dr Reddy's Laboratories sai...
- Dr Reddy's rejigs top deck as North America head quitsVora will be replaced by Alok Sonig, who is currently responsible for the Indian market and is a member of the management council at the co...
- Lesson for India: Why reprocessing of spent fuel from nuclear reactors makes little senseRecent media reports suggest that all is not well within the Bhabha Atomic Research Centre (BARC) in Trombay, Mumbai.
Load More
